University of Arizona Leads Statewide Study of Congenital Heart Defects
News | Congenital Heart | October 24, 2019

October 24, 2019 — Investigators at the University of Arizona Steele Children's Research Center are leading a...

New Study Shows Chronic Epilepsy Associated With Marker of Cardiac Electrical Instability
News | EP Lab | October 24, 2019

October 24, 2019 — LivaNova PLC announced the publication of a new study in...

Michigan Hospital Improves Post-CABG Outcomes Using Proactive Amiodarone Protocol
News | Cardiovascular Surgery | October 23, 2019

October 23, 2019 — Proactive administration of amiodarone to patients recovering from a common heart surgery shows...

BioCardia Initiates Commercial Release of Avance Steerable Introducer
News | Catheters | October 23, 2019

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable...

Frequent Drinking Greater Risk Factor for Heart Rhythm Disorder Than Binge Drinking

Image courtesy of the American Heart Association.

News | Atrial Fibrillation | October 22, 2019

October 22, 2019 —  Drinking small amounts of alcohol frequently is linked with a higher likelihood of...

OmniVision Announces Guinness World Record for Smallest Image Sensor

OmniVision's OVM6948 CameraCubeChip, a fully packaged, wafer-level camera module measuring 0.65mm x 0.65mm x 1.158mm, built on OmniVision's OV6948, winner of the Guinness World Record for “The Smallest Image Sensor Commercially Available.”

News | Cath Lab | October 22, 2019

October 22, 2019 — OmniVision Technologies Inc. announced that its OV6948 camera module is the winner of the...

Greater Left Ventricular Mass Increases Risk of Heart Failure
News | Magnetic Resonance Imaging (MRI) | October 21, 2019

October 21, 2019 — Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger...

FDA Approves Coronary ViperWire Advance With Flex Tip
Technology | Guidewires | October 21, 2019

October 21, 2019 — Cardiovascular Systems Inc. recently announced U.S. Food and Drug Administration (FDA) premarket...

The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's dapagliflozin (Farxiga) to reduce the risk of hospitalization for heart failure (HF) in adults with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors.
Feature | Heart Failure | October 21, 2019 | Dave Fornell, Editor

October 21, 2019 – The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's...

FDA Clears AiCE Image Reconstruction on Canon's Aquilion Precision CT
Technology | Computed Tomography (CT) | October 21, 2019

October 21, 2019 — Canon Medical Systems USA Inc. has received U.S. Food and Drug Administration (FDA) 510(k)...

New Algorithm Expands Neurologists' Ability to Assess for Clot-removing Procedure
News | Stroke | October 18, 2019

October 18, 2019 — An algorithm developed by faculty at The University of Texas Health Science Center at Houston (...

Robocath Successfully Carries Out First Robotic Coronary Angioplasties in Humans

Image courtesy of Robocath

News | Robotic Systems | October 18, 2019

October 18, 2019 — Robocath recently announced the success of its first two...

New Registry to Provide Insight into STEMI Occurrence, Treatment in North India

Image courtesy of UNC School of Medicine

News | Population Health | October 18, 2019

October 18, 2019 — A new study published in Clinical...

Overlay Init